Cargando...
Mesenchymal stem cell therapy in type 2 diabetes mellitus
Type 2 diabetes mellitus (T2DM), which is characterized by the combination of relative insulin deficiency and insulin resistance, cannot be reversed with existing therapeutic strategies. Transplantation of insulin-producing cells (IPCs) was once thought to be the most promising strategy for treating...
Guardado en:
| Publicado en: | Diabetol Metab Syndr |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5433043/ https://ncbi.nlm.nih.gov/pubmed/28515792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13098-017-0233-1 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|